Dublin, Sept. 09, 2019 (GLOBE NEWSWIRE) -- The "United Kingdom Diabetes Market Report: 2019 - 2024" report has been added to ResearchAndMarkets.com's offering.

This report provides an analytical and statistical insight into the UK diabetes market. The report provides both current and future trends in the prevalence, demographical breakup, diagnosis and treatment of diabetes in UK.

The research study serves as an exceptional tool to understand the epidemiology, market trends, therapeutic structure, competitive structure and the outlook of the UK diabetes market.

This report can serve as an excellent guide for investors, researchers, consultants, marketing strategists and all those who are planning to foray into the UK diabetes market in any form.

Comprehensive situation analysis of the UK diabetes epidemiology and its dynamics:

• Historical, current and future prevalence of diabetes in UK
• Historical, current and future prevalence of type-1 and type-2 diabetes in UK
• Historical, current and future prevalence of diabetes in the urban and rural regions in UK
• Historical, current and future prevalence of diabetes among males and females in UK
• Historical, current and future prevalence of diabetes among various age groups in UK
• Historical, current and future diagnosis rates for diabetes in UK
• Historical, current and future drug treatment rates for diabetes in UK

Comprehensive situation analysis of the UK Oral Antidiabetics market and its dynamics:

• Performance of the Oral Antidiabetics market in UK
• Performance of key classes
• Performance of key players
• Market outlook

Comprehensive situation analysis of the UK Insulin market and its dynamics:

• Performance of the Insulin market in UK
• Performance of key classes
• Performance of key players
• Market outlook

Key Topics Covered

1 Preface

2 Scope and Methodology

3 Executive Summary

4 Introduction
4.1 Overview
4.2 Key Industry Trends

5 Diabetes Disease Overview
5.1 What is Diabetes?
5.2 Diabetes Diagnosis and Treatment
5.2.1 Diagnosis
5.2.2 Treatment
5.3 Diabetes Complications

6 UK Diabetes Epidemiology
6.1 Diabetes Population and Prevalence Rates
6.2 Population and Prevalence Rates by Diabetes Type (Type-1 and Type-2)
6.3 Population and Prevalence Rates by Region
6.4 Population and Prevalence Rates by Gender
6.5 Population and Prevalence Rates by Age Group

7 UK Diabetes Market
7.1 Market Overview
7.2 Market Performance
7.3 Market Forecast
7.4 SWOT Analysis
7.4.1 Overview
7.4.2 Strengths
7.4.3 Weaknesses
7.4.4 Opportunities
7.4.5 Threats
7.5 Value Chain Analysis
7.6 Porter's Five Forces Analysis
7.6.1 Overview
7.6.2 Bargaining Power of Buyers
7.6.3 Bargaining Power of Suppliers
7.6.4 Degree of Competition
7.6.5 Threat of New Entrants
7.6.6 Threat of Substitutes
7.7 Market Breakup by Segment
7.7.1 UK Oral Antidiabetics Market
7.7.1.1 Historical Market Trends
7.7.1.2 Market Breakup by Class
7.7.1.3 Market Shares of Key Players
7.7.1.4 Market Forecast
7.7.2 UK Insulin Market
7.7.2.1 Historical Market Trends
7.7.2.2 Market Breakup by Class
7.7.2.3 Market Shares of Key Players
7.7.2.4 Market Forecast

8 Competitive Landscape
8.1 Competitive Structure
8.2 Profiles of Key Players

For more information about this report visit https://www.researchandmarkets.com/r/2d6i1s

Research and Markets also offers Custom Research services providing focused, comprehensive and tailored research.

CONTACT: ResearchAndMarkets.com
Laura Wood, Senior Press Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900